Clinical TrialsSearch results
Number of results: 335
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- LIVES Study Extention
- hypercholesterolemia
- LIVES Study Extension advisory committee
- 2007-09-18
Other
- Phase III Randomized Adjuvant Study of Exemestane Versus Anastrozole Versus Tamoxifen in Hormone-Responsive Postmenopausal Breast Cancer Patients
- hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 04 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Randomized Study to Assess the Efficacy of a Further 5 Years of Anastrozole Treatment for Postmenopausal Women with Breast Cancer Completing 5 Years Anastrozole Containing Adjuvant Endocrine Therapy
- Hormone-responsive postmenopausal primary breast cancer
- AERAS executive committee
- 2007-09-05
Other
- Open-label randomized multicenter study of once daily antiretroviral treatment regimen comparing ritonavir boosted atazanavir to efavirenz
- HIV infectioin
- QD Study Group
- 2005-09-21
Other
- Phase II study of caffeine combined chemotherapy in patients with high- grade bone and soft tissue tumor
- High-grade bone and soft tissue tumor
- Group for "Caffeine combined chemotherapy in patients with high-grade bone and soft tissue tumor"
- 2008-03-25
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- A phase III randomized study of neoadjuvant chemotherapy including trastuzumab + cyclophosphamide + docetaxel in patients with operable HER2 positive breast cancer (JBCRG 10)
- HER2 positive breast cancer
- Japan Breast Cancer Research Group (JBCRG)
- 2009-08-31